SEC Form 4 · accession 0001753926-26-001286
Vivani Medical, Inc. · VANI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald Dwyer
Officer — Chief Business Officer
Period of report
Jul 28, 2026
Accepted (ET)
Jul 30, 2026 · 8:27 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001266806
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock OptionF1 | $1.31 | Jul 28, 2026 | A | 70,000 | A | — | Jul 27, 2036 | Common Stock | 70,000 | 70,000 | D |
| RSUsF2,F3 | — | Jul 28, 2026 | A | 35,000 | A | — | — | Common Stock | 35,000 | 35,000 | D |
Explanation of responses
- F1The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.
- F2Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock.
- F3The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.
Remarks
Exhibit 24 - Power of Attorney.